Positive Study Data and Mounting Expenses for OHR Pharmaceutical Inc (NASDAQ:OHRP)
[[tagnumber 0]][[tagnumber 1]]In late March, the shares of OHR Pharmaceutical Inc (NASDAQ:OHRP) suffered a huge blow on the charts as disappointing clinical study data for its OHR–102 product candidate burnt more than 60 percent...